What's hot

View all perspectives
      Regulatory update @ACRheumDC
      Inflation Reduction
      Planned decrease in 10 drug prices including ETN
      Expect this may be gu

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      Regulatory update @ACRheumDC Inflation Reduction Planned decrease in 10 drug prices including ETN Expect this may be gutted by new administration. Will follow and advocate for drug pricing @RheumNow #ACR24 https://t.co/ZrcMaLD6tu
      Harkins @DrTrishHarkins et al. Novel diagnostic cytokines in treatment naive PMR. Elevations CXCL-9 (100%), MCP-1 (93%),

      Richard Conway RichardPAConway

      9 months 3 weeks ago
      Harkins @DrTrishHarkins et al. Novel diagnostic cytokines in treatment naive PMR. Elevations CXCL-9 (100%), MCP-1 (93%), IL-17A (83%), vs TNF (7%) and IL-6 (67%) @RheumNow #ACR24 Abstr#0881 https://t.co/DbYOn81QJH https://t.co/3eyre00D5d
      119 Congress - prepare for change
      Obamacare subsidies set to expire
      NIH changes and possible reorg

      ACR champions are i

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      119 Congress - prepare for change Obamacare subsidies set to expire NIH changes and possible reorg ACR champions are in gov positions for both parties Focus on affecting change that is practical, possible and improves rheumatology practice @ACRheumDC @LennMcD @RheumNow #ACR24 https://t.co/tcxixdlSWQ
      @LennMcD @ACRheumDC

      Do policies affect medication access, costs, reimbursements, telehealth, or your life as a rheumat

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      @LennMcD @ACRheumDC Do policies affect medication access, costs, reimbursements, telehealth, or your life as a rheumatology provider or patients? Contact - quick and easy! https://t.co/TvMlXiIZQR @RheumNow #ACR24 https://t.co/plnUtl7Kml https://t.co/lFGx7hzlKy
      #Blinded by results? 😊
      #Ocular #involvement in #GPA
      👇
      Helped by #rituximab

      👁️ #GPA
      Difficult

      Proptosis
      Ps

      Janet Pope Janetbirdope

      9 months 3 weeks ago
      #Blinded by results? 😊 #Ocular #involvement in #GPA 👇 Helped by #rituximab 👁️ #GPA Difficult Proptosis Pseudotumour Conjunctivitis Scleritis Vasculitis Ocular muscles - diplopia Small case series ‘author defined’ remission in 80% 👍 #RTX #abst0726 @rheumnow #ACR24 https://t.co/GHptelOTyv
      If high +ANA and NO #rheumatic #disease LOOK 👀 at #LIVER#Autoimmune #hepatitisAnd#alcoholic #liver #dx #ACRBe

      Janet Pope Janetbirdope

      9 months 3 weeks ago

      If high +ANA and NO #rheumatic #disease LOOK 👀 at #LIVER #Autoimmune #hepatitis And #alcoholic #liver #dx #ACRBest #ACR24 @rheumnow abst#0627 https://t.co/EVLUyvpBfD

      Improved fertility in women with RA when treated with a Treat-to-Target (T2T) approach aimed at remission.
      Key findings:

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      Improved fertility in women with RA when treated with a Treat-to-Target (T2T) approach aimed at remission. Key findings: - Shorter time to pregnancy (TTP) in PreCARA cohort (84 days) vs. PARA cohort (196 days). - Increased TNF-inhibitor use and lower NSAID/prednisone use in the… https://t.co/YyD2lpXVRC https://t.co/LH5LMOH8al
      @ACRheumDC
      Check out the ACR policy position statements
      Created by volunteer-led, non-partisan group of GAC committee -

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      @ACRheumDC Check out the ACR policy position statements Created by volunteer-led, non-partisan group of GAC committee - changes based on the needs of the ACR members @cdowneymd https://t.co/oAFfYUct4y @RheumNow #ACR24 https://t.co/MmVd8XYs0j
      Half of the respondents chose #IL17i for #psoriatic #arthritis #PsA Rx for #Achilles #tendonitis

      Interesting as lots
      O

      Janet Pope Janetbirdope

      9 months 3 weeks ago
      Half of the respondents chose #IL17i for #psoriatic #arthritis #PsA Rx for #Achilles #tendonitis Interesting as lots Of data On #enthesitis wIL23i Likely all Effective #PsA Rx helps #tenosynovitis some have ➡️ data on #efficacy ⬆️ bio rationale #ACR24 @RheumNow @ACRheum https://t.co/wzefjsfdaj
      If you are not at the table, you are on the menu

      https://t.co/c4anIn3aue
      @cdowneymd @ACRheumDC

      Join a committee
      Rheum

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      If you are not at the table, you are on the menu https://t.co/c4anIn3aue @cdowneymd @ACRheumDC Join a committee RheumPAC Write a letter Write a post card at ACR Hub at #ACR24 Advocacy office hours with ACR staff #Act4Arthritis & Advocacy 101 on Cap Hill @RheumNow https://t.co/bpilydxEpB
      The post hoc analysis of the SURPASS study evaluated predictors of radiographic spinal progression in axial spondyloarth

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      The post hoc analysis of the SURPASS study evaluated predictors of radiographic spinal progression in axial spondyloarthritis patients treated with IL-17A (secukinumab) or TNF inhibitors over 2 years. Key findings: - New syndesmophytes: 18.2% (SEC 150 mg), 15.8% (SEC 300 mg),… https://t.co/jke6OHdPjZ
      The future use of a panel of immunological urinary biomarkers as a liquid biopsy for the management of lupus nephritis.

      Antoni Chan MD (Prof) synovialjoints

      9 months 3 weeks ago
      The future use of a panel of immunological urinary biomarkers as a liquid biopsy for the management of lupus nephritis. Plenary Abstr#1642 @RheumNow #ACR24 https://t.co/waSRVd7FV7
      @LennMcD @ACRheumDC
      Current congress (118th) - very tight margins, paralyzed by the ‘24 elections. Now in lame duck

      M

      Eric Dein ericdeinmd

      9 months 3 weeks ago
      @LennMcD @ACRheumDC Current congress (118th) - very tight margins, paralyzed by the ‘24 elections. Now in lame duck Many ACR policies made into bills - PA, step rx, copay accumulator, workforce, loan repayment, incr Rx transparency Needs to be passed into law @RheumNow #ACR24 https://t.co/1elEUiUAmh
      @DrLauraCoates presented Sex differences in clinical presentations of PsA:

      -Women present >polyarthritis, enthesitis

      Adela Castro AdelaCastro222

      9 months 3 weeks ago
      @DrLauraCoates presented Sex differences in clinical presentations of PsA: -Women present >polyarthritis, enthesitis and worse PROs which translates to ⬆️ DAPSAs in spite of less Rx progression. -Men more oligoarthritis, axial involvement, higher skin disease. #ACR24… https://t.co/iapZF0nZWX https://t.co/jZ79WfxZwh
      🔥Sex matters in PsA

      🔑Differences in :

      ➡️clinical phenotypes
      ➡️radiographic progression
      ➡️disease im

      Caoilfhionn Connolly CaoilfhionnMD

      9 months 3 weeks ago
      🔥Sex matters in PsA 🔑Differences in : ➡️clinical phenotypes ➡️radiographic progression ➡️disease impact ➡️pt perception of disease ➡️response to Rx #ACR24 @RheumNow https://t.co/iOXQmoxgp0
      How well do you know this week's rheumatology news?
      Take the rheumIQ quiz
      Take the RheumIQ Quiz

      Podcasts

      • ACR24 IL-17 Topic Panel Advancing Care with IL-17 Pathway Insights
      • ACR24 JAK TYK Topic Panel
      • RheumNow Day 1 Recap ACR Convergence 2024 Highlights

      Catch up on Conference Podcasts

      ×